Quick Answer
Pterostilbene Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Mimio improved more over time in all hunger and satiety metrics than placebo (Hunger and Satiety Composite Score Mann-Kendall p = 2.2*10− 16).
Key Takeaways
- 01Mimio improved more over time in all hunger and satiety metrics than placebo (Hunger and Satiety Composite Score Mann-Kendall p = 2.2*10− 16). [Grant AD (2026)]
- 02More participants in the Mimio group improved daily ratings of hunger and appetite compared to placebo, including 91% vs. [Grant AD (2026)]
- 03Mimio significantly reduced total cholesterol, LDL cholesterol, LDL particle number, oxidized LDL, non-HDL cholesterol and fasting glucose compared to placebo (Student’s t-test p < 0.05). [Grant AD (2026)]
- 04This decentralized, double-blind, randomized, placebo-controlled trial investigated the impact of a novel fasting mimetic “Mimio” on hunger, satiety, digestive symptoms, metabolism, cognition and wellbeing in overweight older adults with elevated HbA1c. [Grant AD (2026)]
The current Migaku evidence database contains 1 reusable source document for Pterostilbene Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Mimio improved more over time in all hunger and satiety metrics than placebo (Hunger and Satiety Composite Score Mann-Kendall p = 2.2*10− 16). [Grant AD (2026); evidence level 4]
- More participants in the Mimio group improved daily ratings of hunger and appetite compared to placebo, including 91% vs. [Grant AD (2026); evidence level 4]
- Mimio significantly reduced total cholesterol, LDL cholesterol, LDL particle number, oxidized LDL, non-HDL cholesterol and fasting glucose compared to placebo (Student’s t-test p < 0.05). [Grant AD (2026); evidence level 4]
- This decentralized, double-blind, randomized, placebo-controlled trial investigated the impact of a novel fasting mimetic “Mimio” on hunger, satiety, digestive symptoms, metabolism, cognition and wellbeing in overweight older adults with elevated HbA1c. [Grant AD (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources